Since receiving $3 billion in voter authorized bonds in 2004, the state's publicly-funded stem cell research institute has been beset by one controversy after another. Wranglings with the legislature, potential conflicts of interest in the grant application process, and key questions regarding taxpayer investment have plagued the California Institute for Regenerative Medicine.
But, that's not all.